Gloomy scale density summary statistics from a product trial conducted in Rock Hill, South Carolina, USA in 2019.
Treatment | N | Mean | SD | SE | Median | 95% CI | Minimum | Maximum |
---|---|---|---|---|---|---|---|---|
Dinotefuran | 9 | 0.07 | 0.09 | 0.03 | 0.02 | 0.01–0.13 | < 0.01 | 0.3 |
Pyriproxyfen plus oil | 9 | 0.26 | 0.35 | 0.12 | 0.11 | 0.03–0.50 | 0.03 | 1.09 |
Flupyradifurone T1 | 9 | 0.34 | 0.23 | 0.08 | 0.26 | 0.19–0.49 | 0.14 | 0.88 |
Flupyradifurone T2 | 9 | 0.89 | 0.48 | 0.16 | 1.07 | 0.58–1.21 | 0.19 | 1.42 |
Flupyradifurone T3 | 9 | 0.86 | 0.39 | 0.13 | 0.68 | 0.60–1.12 | 0.41 | 1.57 |
Control | 9 | 1.19 | 0.57 | 0.19 | 1.11 | 0.82–1.56 | 0.55 | 2.31 |